Skip to main content
Erschienen in: Internal and Emergency Medicine 4/2020

04.05.2020 | IM - REVIEW

Cardio-metabolic problem in Egypt

verfasst von: Mona Amin, Amal Radwan, Afaf Hemeda

Erschienen in: Internal and Emergency Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Thirty years ago, chronic conditions such as diabetes, heart disease, and obesity accounted for less than 45% of the global disease burden. Today, they are the leading causes of death and disability worldwide, having surpassed infectious diseases such as HIV/AIDS and malaria. We have understood for decades the roles of ‘classical’ risk factors including elevated LDL-cholesterol, hypertension, elevated blood glucose, and smoking in the pathogenesis of cardiovascular disease. More recent research is continuing to define the contribution of other emerging factors to the risk of developing cardiovascular disease, particularly abdominal obesity that is associated with atherogenic dyslipidemia, insulin resistance, chronic inflammation, and prothrombotic state. All these factors constitute the global cardiometabolic risk that plays a significant role in development of cardiovascular disease.
Literatur
1.
Zurück zum Zitat Srivastava AK (2012) Challenges in the treatment of cardiometabolic syndrome. Indian J Pharmacol 44(2):155–156CrossRef Srivastava AK (2012) Challenges in the treatment of cardiometabolic syndrome. Indian J Pharmacol 44(2):155–156CrossRef
2.
Zurück zum Zitat Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14–23CrossRef Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32:14–23CrossRef
3.
Zurück zum Zitat Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol 89(6):2548–2556CrossRef Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metabol 89(6):2548–2556CrossRef
5.
Zurück zum Zitat Seattle WA (2010) Global burden of diseases, injuries, and risk factors study. Institute for Health Metrics and Evaluation Seattle WA (2010) Global burden of diseases, injuries, and risk factors study. Institute for Health Metrics and Evaluation
6.
Zurück zum Zitat Ibrahim MM (2014) The egyptian hypertension society, Egyptian hypertension guidelines. The Egyptian society of cardiology. Egypt Heart J 66:79–132 Ibrahim MM (2014) The egyptian hypertension society, Egyptian hypertension guidelines. The Egyptian society of cardiology. Egypt Heart J 66:79–132
7.
9.
Zurück zum Zitat Cho NH, Shawb JE, Karurangaa S, Huanga Y et al (2011) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281CrossRef Cho NH, Shawb JE, Karurangaa S, Huanga Y et al (2011) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281CrossRef
10.
Zurück zum Zitat Mowafi M, Khadr Z, Kawachi I et al (2014) Socioeconomic status and obesity in Cairo, Egypt: a heavy burden for all. J Epidemiol Global Health 4:13–21CrossRef Mowafi M, Khadr Z, Kawachi I et al (2014) Socioeconomic status and obesity in Cairo, Egypt: a heavy burden for all. J Epidemiol Global Health 4:13–21CrossRef
11.
Zurück zum Zitat World health Organization (WHO) Report (2017) World health Organization (WHO) Report (2017)
12.
Zurück zum Zitat Farrag A, El Eraky A, El Aroussy W et al (2015) Obesity and other cardiovascular risk factors in Egyptian University Students: magnitude of the problem. Epidemiology 5(1):1000181 Farrag A, El Eraky A, El Aroussy W et al (2015) Obesity and other cardiovascular risk factors in Egyptian University Students: magnitude of the problem. Epidemiology 5(1):1000181
13.
Zurück zum Zitat Ellabany E, Nasser AM (2005–2006) WHO Eastern Mediterranean Regional Office. In: Collaboration with USAID. Cairo Ellabany E, Nasser AM (2005–2006) WHO Eastern Mediterranean Regional Office. In: Collaboration with USAID. Cairo
15.
Zurück zum Zitat Abelaziz A, Fawzy M (2014) Prevalence and pattern of dyslipidemia in ACS patients admitted to medical ICU. In: Zagazig University Hospital. Internal Medicine and Biochemical departments Zagazig University. Z.U.M.J, 20 (3) Abelaziz A, Fawzy M (2014) Prevalence and pattern of dyslipidemia in ACS patients admitted to medical ICU. In: Zagazig University Hospital. Internal Medicine and Biochemical departments Zagazig University. Z.U.M.J, 20 (3)
16.
Zurück zum Zitat Waked I, Esmat G, Elsharkawy A et al (2020) Screening and treatment program to eliminate hepatitis C in Egypt. NEJM 382:12CrossRef Waked I, Esmat G, Elsharkawy A et al (2020) Screening and treatment program to eliminate hepatitis C in Egypt. NEJM 382:12CrossRef
17.
Zurück zum Zitat Haseltine WA (2020) Universal disease screening and treatment—the Egyptian example. NEJM 382:1CrossRef Haseltine WA (2020) Universal disease screening and treatment—the Egyptian example. NEJM 382:1CrossRef
Metadaten
Titel
Cardio-metabolic problem in Egypt
verfasst von
Mona Amin
Amal Radwan
Afaf Hemeda
Publikationsdatum
04.05.2020
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 4/2020
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02346-8

Weitere Artikel der Ausgabe 4/2020

Internal and Emergency Medicine 4/2020 Zur Ausgabe

CE - MEDICAL ILLUSTRATION

Mount Fuji Sign

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.